Loading clinical trials...
Loading clinical trials...
A Phase 3, Open-Label, Randomized, Active-Controlled Study of the Efficacy and Safety of Roxadustat (FG-4592) in the Maintenance Treatment of Anemia in Subjects With End Stage Renal Disease (ESRD) on Stable Dialysis
Conditions
Interventions
Epoetin Alfa
Roxadustat
Locations
76
United States
Research Center
Phoenix, Arizona, United States
Research Center
Pine Bluff, Arkansas, United States
Research Center
Chula Vista, California, United States
Research Center
Chula Vista, California, United States
Research Center
La Mesa, California, United States
Research Center
Long Beach, California, United States
Start Date
January 15, 2015
Primary Completion Date
September 19, 2018
Completion Date
September 19, 2018
Last Updated
October 29, 2021
Lead Sponsor
Kyntra Bio
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions